查看完整行情页>>

|

货币单位:美元(USD)

爱德华兹生命科学公司

Edwards Lifesciences Corp. (ew)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Todd J. Brinton Todd J. Brinton is the founder of BioParadox, Inc. (founded in 2008) and Shockwave Medical, Inc. (founded in 2009). He held the title of Director at BioParadox, Inc. and Director at Shockwave Medical, Inc. until 2019. Currently, he is a Director at Alliance for Southern California Innovation, Director at International Society For Cardiovascular Translational, Chief Scientific Officer & VP-Advanced Technology at Edwards Lifesciences Corp., and Venture Partner at Sonder Capital Management LLC. Dr. Brinton's former jobs include being a Professor at Stanford University and Stanford University School of Medicine. He received his undergraduate degree from the University of California San Diego and his doctorate from Chicago Medical School.
Michael A. Mussallem Michael A. Mussallem is currently the Chairman & Chief Executive Officer at Edwards Lifesciences LLC since 2000. He is also the Non-Executive Chairman at Edwards Lifesciences Corp. since 2023. Additionally, he serves as a Director at the Healthcare Leadership Council, a Director at the Advanced Medical Technology Association since 2010, a Director at the OCTANe Foundation for Innovation, a Trustee at the Rose-Hulman Institute of Technology, Inc. since 2017, a Trustee at the University of California, Irvine Foundation since 2008, and a Board of Advisor at InCube Venture Partners LLC. He has also held former positions as a Director at Advanced Medical Optics, Inc. from 2002 to 2009, a Director at the California Healthcare Institute from 1996 to 2014, and as Vice President-CardioVascular Group at Baxter International, Inc. from 1994 to 2000. He also served as President at CAS Medical Systems, Inc. Mr. Mussallem obtained his undergraduate degree from the Rose-Hulman Institute of Technology, Inc.
Scott B. Ullem Scott B. Ullem is currently a Director at Berry Global, Inc., an Independent Director at Illumina, Inc., and a Director at Egnite, Inc. He was previously the Chief Financial Officer & Vice President at Edwards Lifesciences Corp. and the Chief Financial Officer at Edwards Lifesciences Foundation. Ullem has also held former positions as a Managing Director at Bank of America Corp., an Independent Director at Berry Global Group, Inc., a Managing Director at Banc of America Securities LLC, a Director at The Aspen Institute, Inc., the Chief Financial Officer & Vice President at Bemis Co., Inc., and the Chief Financial Officer & Vice President at CAS Medical Systems, Inc. He also worked as an MD-Investment Banking Services Group at Goldman Sachs & Co. LLC. Ullem received his undergraduate degree from DePauw University and his MBA from Harvard Business School.
Bernard J. Zovighian Bernard J. Zovighian is currently the President, Chief Executive Officer & Director at Edwards Lifesciences Corp. He is also the President at Edwards Lifesciences LLC. Previously, he served as the President-Advanced Sterilization Products at Johnson & Johnson. Mr. Zovighian completed his undergraduate degree at the University of Marseille and holds an MBA from Euromed Management.
Ramona Sequeira Ramona Sequeira is currently an Independent Director at Edwards Lifesciences Corp., a Trustee at Harvey Mudd College, President at Takeda Pharmaceuticals U.S.A., Inc., and a Trustee at Lake Forest Academy. Her former jobs include being the Chairman at Pharmaceutical Research & Manufacturers of America, Associate Director-Neuroscience Marketing at Eli Lilly & Co., Director at The Executives Club of Chicago, Director at The Association of the British Pharmaceutical Industry, and Director at Innovation Development Institute, Inc. She received her undergraduate degree from the University of Toronto and her MBA from McMaster University.
Martha H. Marsh Martha H. Marsh is currently the Lead Independent Director at Edwards Lifesciences Corp., a Director at Candsecent Health, Inc., and a Director at Teichert, Inc. She previously served as the Chief Executive Officer at Davis Medical Center, Stanford Health Care, UC Davis Medical Center, and UC Davis Health System. She was also the President & Chief Executive Officer at Matthew Thornton Health Plan, Inc. Ms. Marsh has held positions as the Chairman-Trustee Board at California Hospital Association and Chairman at The California Association of Hospitals & Health Systems. Additionally, she served as the Co-Chairman of the National Infrastructure Advisory Council. Ms. Marsh was an Independent Director at Owens & Minor, Inc. from 2012 to 2019 and a Director at Thoratec Corp. from 2014 to 2015. She is currently an Independent Director at AMN Healthcare Services, Inc. until 2024. Ms. Marsh has a background in healthcare management and has held various leadership positions in the industry. She holds an undergraduate degree from Rochester Christian University and graduate degrees, including an MBA, from The Trustees of Columbia University in The City of New York.
Kieran Thomas Gallahue Kieran Thomas Gallahue is currently the Chairman at Signifier Medical Technologies Ltd. He is also an Independent Director at Edwards Lifesciences Corp., a Director at Nucleus Biologics LLC, a Director at Systems Oncology LLC, and an Independent Director at Envista Holdings Corp. Previously, Mr. Gallahue held several positions including President, Chief Executive Officer & Director at ResMed, Inc., Chairman & Chief Executive Officer at CareFusion Corp., Chairman at Intersect ENT, Inc., Independent Non-Executive Director at Arena Pharmaceuticals, Inc., Independent Director at Philips Image Guided Therapy Corp., Director at Advanced Medical Technology Association, Principal at GE Aerospace, Principal at Procter & Gamble Co., President & Chief Financial Officer at Ngen, Inc., and Vice President-Critical Care Business Unit at Instrumentation Laboratory Co.Mr. Gallahue obtained an undergraduate degree from Rutgers State University of New Jersey and an MBA from Harvard Business School.
Paul A. LaViolette Paul A. LaViolette is currently serving as the Chairman at Endotronix, Inc., CardioFocus, Inc., Corvia Medical, Inc., and as an Independent Director at Edwards Lifesciences Corp. He is also a Director at several companies including Direct Flow Medical, Inc., CSA Medical, Inc., Solsys Medical LLC, The Medical Device Manufacturers Association, Cibiem, Inc., Coridea NC2, Inc., Soffio Medical, Inc., Axon Therapies, Inc., Zerigo Health, Inc., Bardy Diagnostics, Inc., Vibrato Medical, Inc., and Stimwave Technologies, Inc. Additionally, he is the Managing Partner & Chief Operating Officer at SV Health Investors LLC. Previously, Mr. LaViolette held positions such as Chairman & Chief Executive Officer at Stimwave LLC, Chairman at Misonix, Inc., Chairman at TransEnterix, Inc., Chairman at TranS1, Inc., Chairman at SafeStitch Medical, Inc., Chairman at Asensus Surgical, Inc., Independent Director at Thoratec Corp., Independent Director at Conceptus, Inc., and President-USCI Division at C. R. Bard, Inc. (New Jersey). He also served as the Chief Operating Officer at Boston Scientific Corp. Mr. LaViolette obtained an MBA from Boston College and completed his undergraduate studies at Fairfield University.
Steven R. Loranger Steven R. Loranger is currently the Chairman of ITT Defense Products & Services. He is also an Independent Director at Edwards Lifesciences Corp., the Director of The National Air & Space Museum, the Director of the Smithsonian National Air & Space Museum, a Director at the Medal of Honor Foundation, Inc., and an Independent Director at Xylem, Inc. In his former positions, Mr. Loranger served as the CEO-Engines, Systems & Services Business at AlliedSignal, Inc. from 1981 to 2002. He was also the Chief Executive Officer of FlightSafety International, Inc. and the Chairman, President & Chief Executive Officer of ITT Corp. from 2004 to 2011. Additionally, he held the position of CEO-Engines, Systems & Services Business at Honeywell International, Inc. from 1981 to 2002. He served as an Independent Director at FedEx Corp. from 2006 to 2014 and as a Director at The Business Roundtable and The Wings Club. He was a Director at Exelis, Inc. from 2011 to 2013 and the Chief Operating Officer & Executive Vice President at Textron, Inc. from 2002 to 2004. He also held positions at Textron Fastening Systems, Inc., Aerospace Industries Association, and Bendix Truck Brake Group. Mr. Loranger obtained his undergraduate and graduate degrees from The University of Colorado.
Nicholas J. Valeriani Nicholas J. Valeriani is currently the Chairman of Conor Medsystems LLC and holds multiple director positions in companies such as Edwards Lifesciences Corp., Change Healthcare Engagement Solutions, Inc., Surgalign Spine Technologies, Inc., SPR Therapeutics, Inc., Reagan-udall Foundation, Clyra Medical Technologies, Inc., AgNovos Healthcare LLC, Roka Bioscience, Inc., and RTI Surgical, Inc. He previously served as the Chief Executive Officer-West Health at The Gary & Mary West Health Institute, Chairman at Ortho-Clinical Diagnostics, Inc., and held various director positions in companies such as Sorrento Tech, Inc., Robert Wood Johnson University Hospital, Inc., Gary & Mary West Health Policy Center, Reflexion Health, Inc., and Center for Medical Interoperability. Valeriani also served as Vice President-Strategy & Growth at Johnson & Johnson. He holds an MBA from Rutgers Business School and an undergraduate degree from Rutgers University School of Engineering.
Leslie Stone Heisz Leslie Stone Heisz is currently an Independent Director at Edwards Lifesciences Corp., a Director at Kaiser Permanente, Inc., a Director at Kaiser Foundation Hospitals, a Director at Kaiser Permanente of Northern California, a Director at Kaiser Permanente of Mid Atlantic States, a Director at Kaiser Foundation Health Plan, Inc., and an Independent Trustee at Public Storage. Previously, Ms. Heisz held positions as a Director at International Game Technology, an Independent Director at HCC Insurance Holdings, Inc., an Independent Director at Ingram Micro, Inc., a Director at Eldorado Resorts LLC, a Managing Director at Lazard Frères & Co. LLC, a Managing Director at Dresdner Kleinwort Wasserstein-Grantchester, Inc., an Independent Director at Towers Watson & Co., and a Senior Consultant at Pricewaterhouse LLP. Ms. Heisz also has an undergraduate degree from the University of California, Los Angeles and an undergraduate and MBA degree from UCLA Anderson School of Management.